DIA
NVO

Davidson Investment Advisors’s Novo Nordisk NVO Stock Holding History

Davidson Investment Advisors’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-800
Closed -$14K – 219
2016
Q4 		$14K Hold
800
– – ﹤0.01% 186
2016
Q3 		$16K Hold
800
– – ﹤0.01% 173
2016
Q2 		$21K Hold
800
– – ﹤0.01% 159
2016
Q1 		$21K Buy
+800
New +$21.4K ﹤0.01% 184

Other funds holding NVO

Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $4.64B AUM 35.47% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Fayez Sarofim & Co
Fayez Sarofim & Co Houston, Texas $42.5B AUM 18.19% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $146B AUM 55.73% 1-Year Est. Return
SGA
Sustainable Growth Advisers Stamford, Connecticut $10.2B AUM 1.48% 1-Year Est. Return

Davidson Investment Advisors's NVO Position: Q1 2017 in Review

Davidson Investment Advisors sold out of Novo Nordisk (NVO) in Q1 2017, closing a stake of 800 shares — an estimated $14K sold.

Davidson Investment Advisors first reported a position in NVO in Q1 2016 and held it in 4 quarters. The position peaked at $21K in Q2 2016. 463 funds tracked by Wall St. Rank hold NVO as of Q1 2017.

  • Davidson Investment Advisors reported no remaining Novo Nordisk position as of Q1 2017 after selling out during the quarter.
  • Davidson Investment Advisors sold 800 Novo Nordisk shares in Q1 2017, an estimated $14K.
  • Davidson Investment Advisors first reported a position in Novo Nordisk in Q1 2016 and held it in 4 quarters.
  • Davidson Investment Advisors's Novo Nordisk position peaked at $21K in Q2 2016.
  • 463 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2017.

Based on Davidson Investment Advisors's 13F filing for Q1 2017, filed 12 May 2017.